Supplementary Methods: Real-time (q)PCR. Table S1: Comparison of the effects of chemotherapeutic agents on cell-surface CXCR4 and CD26 on remaining viable HT-29 cells following 48 h of exposure. Table S2: Estimation results for regression model with cell Marker and Drug as covariates. Table S3: Confidence level tests for percent change between cell populations. (DOC 53 kb
The figure shows a sample results of CK20 RT-PCR from 16 patients, including two positive controls (...
Additional file1: Table S1. Characteristics of the colon cancer patients included in mass cytometry ...
Figure S1. The combination of CTX / L-NIL reverses the cold tumor microenvironment. Figure S2. CTX /...
Anticancer agents decrease CXCR4+ cells and increase cell-surface expression of CD26 in the HT-29 ce...
Treatment with diverse anticancer agents increases CD26 while also enhancing CD44+, but lowering CD1...
Chemotherapeutic drugs increase CD26 protein expression on live cells but do not alter immunoreactiv...
Table S1. Frequency of KMT2/MLL Mutations in Colon Cancer Cell Lines. Table S2. Sequences of individ...
Comprehensive summary of CRC cell viability results after sequential treatments with 5-azanucleoside...
Table S1, shRNA Sequences; Table S2, antibodies for immunoblot; Table S3, antibodies for immunofluor...
Figure S1. CXCL17 did not affect the cell proliferation and migration of breast cancer. The effect o...
Dose response curve and chemoprotection of leukemia cells by MSC. a-c Dose response curve showing pe...
Primer sequences for quantitative real-time-PCR. Sequences of primers (5′-3′) used for quantitative ...
Combinatorial treatments increase CRC cell apoptosis. Annexin V-FITC/PI-double staining of HCT116, D...
Figure S4. The trans-well migration potential of SDCSC-exosome-treated neutrophils. (A) A flow chart...
Viability assay of colorectal cell lines treated by chemotherapeutic drugs combined or not with Lova...
The figure shows a sample results of CK20 RT-PCR from 16 patients, including two positive controls (...
Additional file1: Table S1. Characteristics of the colon cancer patients included in mass cytometry ...
Figure S1. The combination of CTX / L-NIL reverses the cold tumor microenvironment. Figure S2. CTX /...
Anticancer agents decrease CXCR4+ cells and increase cell-surface expression of CD26 in the HT-29 ce...
Treatment with diverse anticancer agents increases CD26 while also enhancing CD44+, but lowering CD1...
Chemotherapeutic drugs increase CD26 protein expression on live cells but do not alter immunoreactiv...
Table S1. Frequency of KMT2/MLL Mutations in Colon Cancer Cell Lines. Table S2. Sequences of individ...
Comprehensive summary of CRC cell viability results after sequential treatments with 5-azanucleoside...
Table S1, shRNA Sequences; Table S2, antibodies for immunoblot; Table S3, antibodies for immunofluor...
Figure S1. CXCL17 did not affect the cell proliferation and migration of breast cancer. The effect o...
Dose response curve and chemoprotection of leukemia cells by MSC. a-c Dose response curve showing pe...
Primer sequences for quantitative real-time-PCR. Sequences of primers (5′-3′) used for quantitative ...
Combinatorial treatments increase CRC cell apoptosis. Annexin V-FITC/PI-double staining of HCT116, D...
Figure S4. The trans-well migration potential of SDCSC-exosome-treated neutrophils. (A) A flow chart...
Viability assay of colorectal cell lines treated by chemotherapeutic drugs combined or not with Lova...
The figure shows a sample results of CK20 RT-PCR from 16 patients, including two positive controls (...
Additional file1: Table S1. Characteristics of the colon cancer patients included in mass cytometry ...
Figure S1. The combination of CTX / L-NIL reverses the cold tumor microenvironment. Figure S2. CTX /...